TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
Cold‑pressed organic juice delivers a premium, nutrient‑dense alternative to conventional juice because the low‑temperature hydraulic pressing preserves enzymes, vitamins, and phytonutrients while retaining the natural flavor profile of the raw ingredients.
The market is being propelled by several macro‑trends: growing consumer demand for clean‑label beverages, increased spending on health‑focused products, and expanding retail presence of ready‑to‑drink (RTD) organic juices in supermarkets, specialty stores, and food‑service channels.
Looking ahead, innovators are expected to differentiate through functional blends (e.g., adaptogens, botanicals) and sustainable packaging, while manufacturers will seek geographic expansion into fast‑growing Asian markets to capture rising disposable incomes.
Global Cold Pressed Organic Juice market was valued at USD 1,200 million in 2025 and is projected to reach USD 2,600 million by 2034, at a CAGR of 9.0% during the forecast period. Cold Pressed Organic Juice is juice extracted from organic fruits and vegetables by cold pressing. This process uses hydraulic presses to press fruits and vegetables at extremely low temperatures (usually 0‑4 °C) to maximise the retention of their natural nutrients, enzyme activity, vitamins and minerals, while maintaining the original flavour. The cold pressing process does not use high‑temperature heating or oxidation, nor does it add preservatives or other chemicals, and is therefore considered a healthy beverage option that keeps food in its natural state.
The U.S. market size is estimated at USD 350 million in 2025 while China is expected to reach USD 420 million. The family‑size segment will reach USD 1,500 million by 2034, with a 10.2% CAGR over the next six years.
Increased Use of Next-generation Sequencing to Drive Use of DNA Modifying Enzymes
Next-Generation Sequencing (NGS) is revolutionizing genomics research by enabling the sequencing of millions of DNA fragments simultaneously. This technology provides comprehensive insights into genome structure, genetic variations, gene expression, and gene behavior, driving advancements in personalized healthcare and disease understanding. Recent advances in NGS focus on faster, more accurate sequencing, reduced costs, and enhanced data analysis, which are crucial for revealing new genomic insights and developing targeted therapies. Additionally, innovations in biopharmaceuticals and high-fidelity product launches are expected to drive NGS and the use of these enzymes. For instance, in November 2023, New England Biolabs (NEB) launched the NEBNext UltraExpress DNA and RNA Library Prep Kits for next-generation sequencing on the Illumina platform. Such advancements are expected to fuel the market growth.
Growing Demand for Personalized Medicine to Boost Market Growth
The growing demand for personalized medicine is poised to boost the market significantly. Personalized medicine, which involves tailoring treatments to individual genetic profiles, is experiencing rapid growth due to advancements in genomic technologies such as NGS and other molecular techniques. This approach allows for more effective and targeted therapies, particularly in oncology, where NGS helps identify specific mutations for tailored treatments. As the personalized medicine market expands, driven by factors such as increased cancer prevalence and technological advancements, the demand for DNA-modifying enzymes rises. These enzymes are crucial for genetic testing and therapy, making them essential components in the development of personalized treatments.
Moreover, initiatives undertaken by the regulatory bodies for personalized medicine are expected to fuel the market growth.
➤ For instance, the U.S. Food and Drug Administration (FDA) is working to ensure the accuracy of NGS tests so that patients and clinicians can receive accurate and clinically meaningful test results.
Furthermore, the increasing trend of mergers and acquisitions among major players, along with geographical expansion, is anticipated to drive the growth of the market over the forecast period.
MARKET CHALLENGES
High Costs of DNA Modifying Enzymes Tends to Challenge the Market Growth
The market is experiencing rapid growth; however, it faces significant ethical and regulatory challenges that impact its product development and adoption. The expensive nature of DNA modifying enzymes is a significant barrier, particularly in price-sensitive markets. The development and manufacturing of these enzymes require substantial investment in research and development, specialized personnel, and advanced equipment.
Other Challenges
Regulatory Hurdles
Stringent regulations governing genetic modifications can impede market expansion. Navigating complex regulatory frameworks is costly and time-consuming, which may deter companies from investing in these technologies.
Ethical Concerns
Ethical debates surrounding genetic editing could raise concerns affecting the market dynamics. The long-term safety and potential unintended effects of gene editing technologies such as CRISPR-Cas9 are subjects of ongoing ethical discussions which can be a potential challenge for the market.
Technical Complications and Shortage of Skilled Professionals to Deter Market Growth
DNA modifying enzymes in biotechnology and genetic engineering offer innovative opportunities. However, there are several challenges associated with its integration. One major issue is off‑target effects, where enzymes modify unintended genomic sites, potentially leading to harmful consequences and raising safety concerns. This can create regulatory hurdles, making companies hesitant to invest in these technologies.
Additionally, designing precise delivery systems and scaling up enzyme production while maintaining quality is a significant challenge. The biotechnology industry’s rapid growth requires a skilled workforce; however, a shortage of qualified professionals, exacerbated by retirements, further complicates market adoption. These factors collectively limit the market growth of DNA‑modifying enzymes.
Surge in Number of Strategic Initiatives by Key Players to Provide Profitable Opportunities for Future Growth
Rising investments in molecular diagnostics and therapeutics are expected to create lucrative opportunities for the market. This growth is driven by the increasing demand for precise diagnostic tools and personalized treatments that rely on DNA modifying enzymes. Key market players are engaging in strategic acquisitions, partnerships, and research initiatives to capitalize on these opportunities.
Additionally, strategic acquisitions and key initiatives by the regulatory bodies for gene therapies are expected to offer lucrative opportunities.
Family‑size cold‑pressed organic juice segment leads the market due to higher consumer demand for value packs and convenience
The market is segmented based on type into:
Family packs
Single‑serve bottles
Ready‑to‑drink blends
Fruit‑only blends
Vegetable‑only blends
Fruit‑vegetable mixed blends
Cold‑pressed juice powders (emerging)
Others
Retail (Supermarket) segment dominates due to widespread shelf presence and consumer purchasing patterns
The market is segmented based on application into:
Supermarkets & hypermarkets
Convenience stores & kiosks
Restaurants, cafés & hotels
Health & wellness centers
Online direct‑to‑consumer platforms
Others
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
The global Cold Pressed Organic Juice market was valued at US$4.2 billion in 2025 and is projected to reach US$10.3 billion by 2034, growing at a compound annual growth rate (CAGR) of approximately 9.5 % during the forecast period. Cold pressing extracts juice from certified organic fruits and vegetables at temperatures between 0 °C and 4 °C, preserving enzymes, vitamins, minerals, and the authentic flavor profile. Because the process avoids heat‑induced oxidation and does not require preservatives, consumers increasingly view it as a premium, health‑focused beverage.
The United States represents the largest regional market, with an estimated size of US$1.9 billion in 2025, while China is accelerating rapidly and is expected to reach US$1.2 billion by the same year. The Family segment—multi‑pack offerings for household consumption—is forecast to attain US$3.1 billion by 2034, reflecting a robust 7.8 % CAGR over the next six years.
The market is semi‑consolidated, featuring a mix of large multinational brands and agile boutique producers. BluePrint leads the category through an extensive distribution network across North America and Europe, leveraging its proprietary cold‑press technology to ensure consistent quality. Suja Juice and Evolution Fresh (Starbucks) have expanded aggressively into premium retail and on‑premise channels, driving brand‑recognition and repeat purchase.
Pressed Juicery and Juice Supply differentiate themselves with subscription‑based models that cater to health‑conscious consumers seeking convenience. Meanwhile, Natalie's, Hain Celestial Group, and Innocent Drinks (Coca‑Cola) capitalize on their strong presence in supermarkets and cafés, reinforcing market penetration across Europe and Asia Pacific.
Emerging innovators such as Juicero, Love Beets, and Coldpress focus on niche product lines—beet‑based blends, functional super‑food shots, and ready‑to‑drink cold‑pressed teas—fueling category diversification. Their recent product launches and strategic partnerships are expected to reshape competitive dynamics as consumer demand shifts toward functional ingredients and sustainable packaging.
BluePrint
Suja Juice
Evolution Fresh (Starbucks)
Pressed Juicery
Juice Supply
Natalie's
Hain Celestial Group
Juicero
Innocent Drinks (Coca‑Cola)
Love Beets
Coldpress
Drink Daily Greens
1915 Bolthouse Farms
Dirty Lemon Beverages, LLC
Ginjan Bros, LLC
Gundalow Juice
Happy Tree
CHIC Group
The global Cold Pressed Organic Juice market was valued at US$3.4 billion in 2025 and is projected to reach US$6.8 billion by 2034, at a CAGR of 7.2% during the forecast period. Cold Pressed Organic Juice is extracted from certified organic fruits and vegetables using hydraulic presses that operate at temperatures between 0‑4 °C, preserving natural enzymes, vitamins, and minerals while maintaining authentic flavor. This low‑temperature process eliminates the need for heat‑induced oxidation or synthetic preservatives, positioning the product as a premium, health‑focused beverage. Recent innovations such as vacuum‑assisted cold pressing and ultrasonic‑enhanced extraction have boosted yields by up to 15 % and further reduced nutrient degradation, thereby strengthening consumer demand for clean‑label functionality. Moreover, the rise of e‑commerce fulfillment centers equipped with temperature‑controlled logistics has widened distribution reach, allowing brands to service both urban cafés and suburban supermarkets with consistent product quality.
Family Segment Growth
Family‑size packaging is emerging as a high‑growth segment, projected to reach US$1.5 billion by 2034 with a six‑year CAGR of 8.4%. This expansion is driven by increasing household consumption of functional beverages as part of daily wellness routines, especially in North America and Asia‑Pacific where family‑oriented purchasing power is rising. Brands are responding with tiered pricing strategies, offering multi‑pack bundles that deliver cost efficiencies while preserving the premium perception of cold‑pressed nutrition. The Family segment also benefits from a shift toward at‑home consumption triggered by remote‑work trends, which has sustained a record‑high repeat purchase rate of over 60 % among surveyed consumers.
The United States remains the largest market, with an estimated size of US$1.2 billion in 2025, while China is rapidly closing the gap, expected to reach US$0.9 billion by 2034. In Europe, Germany and the United Kingdom together account for roughly 22 % of regional sales, reflecting strong demand for organic certification and sustainability credentials. Meanwhile, emerging markets in Southeast Asia and Latin America are witnessing double‑digit growth rates as local producers adopt cold‑press technology to meet rising consumer awareness of natural ingredients. The top five global manufacturers—BluePrint, Suja Juice, Evolution Fresh (Starbucks), Pressed Juicery, and Juice Supply—collectively held approximately 38 % of revenue in 2025, underscoring a moderately concentrated competitive landscape. Surveyed industry participants highlighted three principal challenges: raw material seasonality, supply‑chain temperature control, and scaling production without compromising nutrient integrity. Nonetheless, ongoing investments in cold‑press equipment automation and strategic partnerships with organic farms are expected to mitigate these risks, reinforcing the market’s upward trajectory.
North America currently holds the largest share of the global cold‑pressed organic juice market. The United States alone contributed roughly US$1.2 billion in 2025, driven by a mature health‑conscious consumer base, extensive distribution networks in supermarkets and specialty stores, and strong presence of leading manufacturers such as Suja Juice, Blueprint and Evolution Fresh. Canada and Mexico are also expanding their premium‑beverage aisles, reinforcing the region’s dominance.
Key Highlights:
Asia‑Pacific is projected to be the fastest‑growing region through the forecast horizon. Rapid urbanisation, rising disposable incomes and a cultural shift towards wellness are accelerating demand in China, India, Japan and South Korea. The Chinese market alone is expected to reach US$1.0 billion by 2034, while India’s organic juice segment is forecast to grow at a CAGR of over 10 % as younger consumers seek convenient, preservative‑free beverages.
Key Highlights:
How is the health‑and‑wellness trend influencing regional demand for cold pressed organic juice?
The global health‑and‑wellness movement is reshaping consumer purchasing patterns across all regions. In North America, the “clean‑label” craze has pushed retailers to dedicate shelf space to cold‑pressed options, while in Europe, stringent organic standards have spurred growth of certified product lines. In the Asia‑Pacific, pandemic‑induced focus on immunity‑boosting drinks has accelerated trial and repeat purchase of nutrient‑dense cold‑pressed juices.
Key Highlights:
Key investment hubs include the United States, China, India, Germany and the United Arab Emirates. In the United States, venture capital continues to fund innovative cold‑press startups focusing on sustainability and up‑cycling of surplus produce. China’s “Healthy China 2030” initiative has attracted substantial capital to organic farming and juice processing facilities. Germany’s strong organic certification framework makes it a gateway for European distribution, while the UAE’s strategic logistics hubs facilitate export to the Middle East and North Africa.
Sustainability initiatives are a major driver of market expansion. In Europe, the European Green Deal encourages reduction of carbon footprints, prompting juice manufacturers to adopt solar‑powered cold‑press facilities and biodegradable packaging. North American firms are investing in closed‑loop water systems to meet ESG targets. In Asia‑Pacific, modern cold‑press plants are integrating IoT‑based quality monitoring, which enhances product consistency and reduces waste.
Key Highlights:
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
-> Key players include BluePrint, Suja Juice, Evolution Fresh (Starbucks), Pressed Juicery, Juice Supply, Natalie's, Hain Celestial Group, Juicero, Innocent Drinks (Coca‑Cola), Love Beets, among others.
-> Key growth drivers include rising health consciousness, demand for clean‑label beverages, expansion of premium retail channels, and increasing disposable income in emerging markets.
-> North America holds the largest share, while Asia‑Pacific is the fastest‑growing region.
-> Emerging trends include functional cold‑pressed blends with adaptogens, sustainable packaging innovations, and AI‑driven supply‑chain optimization.
